"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which promises results in 30 minutes—for myself.

It was quick, and afterward, I donned a Band-Aid with the Truvian logo. In the next room ... some high-profile figures in laboratory and diagnostics. Dr. Tina Nova, former president and CEO ...

Metropolis Healthcare has collaborated with Roche Diagnostics India to introduce a self-sampling human papillomavirus (HPV) DNA test for cervical cancer screening. “The self-sampling HPV DNA ...

Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...

Morgan Stanley initiated coverage of Roche (RHHBY) with an Equal Weight rating and CHF 305 price target The firm sees the end of Roche’s ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF345.00. The company’s shares closed ...

If you ever had cancer or were tested for it, there’s a good chance Roche Tissue Diagnostics played a role behind the scenes. The Tucson-area company has emerged as a global leader in ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit ...